BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND PDGFRA, MGC74795, 5156, ENSG00000134853, PDGFR2, CD140A, Rhe-PDGFRA, CD140a, P16234 AND Treatment
22 results:

  • 1. [Long-term outcome of patients with rectal cancer who achieve complete or near complete clinical responses after neoadjuvant therapy: a multicenter registry study of data from the Chinese Watch and Wait Database].
    Zhao YM; Wang WH; Zhang W; Wang L; Li S; Wang JW; Liao LE; Yu GY; Sun Z; Qu YL; Gong Y; Lu Y; Wu T; Li YF; Wang Q; Zhao GH; Xiao Y; Ding PR; Zhang Z; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):372-382. PubMed ID: 38644243
    [No Abstract]    [Full Text] [Related]  

  • 2. Establishment and Validation of Novel Prognostic Subtypes in Hepatocellular Carcinoma Based on Bile Acid Metabolism Gene Signatures Using Bulk and Single-Cell RNA-Seq Data.
    Qu Y; Gong X; Zhao Z; Zhang Z; Zhang Q; Huang Y; Xie Q; Liu Y; Wei J; Du H
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255993
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The multikinase inhibitor axitinib in the treatment of advanced hepatocellular carcinoma: the current clinical applications and the molecular mechanisms.
    Jiang H; Liao J; Wang L; Jin C; Mo J; Xiang S
    Front Immunol; 2023; 14():1163967. PubMed ID: 37325670
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of artemyrianolide H derivatives as potential antihepatoma agents.
    Li TZ; Yang XT; Ma WJ; Ma YB; Li FJ; Wang YC; Chen JJ
    Bioorg Chem; 2023 Aug; 137():106617. PubMed ID: 37267793
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A cohesin-associated gene score may predict immune checkpoint blockade in hepatocellular carcinoma.
    Liu CZ; Li JD; Chen G; He RQ; Lin R; Huang ZG; Li JJ; Du XF; Lv XP
    FEBS Open Bio; 2022 Oct; 12(10):1857-1874. PubMed ID: 36052535
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Rare case of a duodenal de novo dedifferentiated gastrointestinal stromal tumour.
    Shah PA; Babu R; Uthaiah SB; Patil S
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33962926
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. BRAF mutations in KIT/pdgfra positive gastrointestinal stromal tumours (GISTs): Is their frequency underestimated?
    Jašek K; Váňová B; Grendár M; Štanclová A; Szépe P; Hornáková A; Holubeková V; Plank L; Lasabová Z
    Pathol Res Pract; 2020 Nov; 216(11):153171. PubMed ID: 32836055
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Knockdown of LINC00467 contributed to Axitinib sensitivity in hepatocellular carcinoma through miR-509-3p/pdgfra axis.
    Li W; He Y; Chen W; Man W; Fu Q; Tan H; Guo H; Zhou J; Yang P
    Gene Ther; 2021 Nov; 28(10-11):634-645. PubMed ID: 32221502
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A patient-derived xenograft and a cell line derived from it form a useful preclinical model for small bowel adenocarcinoma.
    Yamano T; Kubo S; Tomita N
    Cancer Med; 2020 May; 9(10):3337-3343. PubMed ID: 32168428
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Gastrointestinal stromal tumours (GISTs): French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNIcancer, SFCD, SFED, SFRO).
    Landi B; Blay JY; Bonvalot S; Brasseur M; Coindre JM; Emile JF; Hautefeuille V; Honore C; Lartigau E; Mantion G; Pracht M; Le Cesne A; Ducreux M; Bouche O; ; ; ; ; ; ;
    Dig Liver Dis; 2019 Sep; 51(9):1223-1231. PubMed ID: 31387778
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Molecular profiling of the biphasic components of hepatic carcinosarcoma by the use of targeted next-generation sequencing.
    Zhang X; Bai Q; Xu Y; Wang W; Chen L; Han J; Zhu H; Zhang Z; Hou Y; Zhou J; Zhou Y; Ji Y
    Histopathology; 2019 May; 74(6):944-958. PubMed ID: 30629754
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Lenvatinib as a therapy for unresectable hepatocellular carcinoma.
    Spallanzani A; Orsi G; Andrikou K; Gelsomino F; Rimini M; Riggi L; Cascinu S
    Expert Rev Anticancer Ther; 2018 Nov; 18(11):1069-1076. PubMed ID: 30220234
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Multidisciplinary treatment for High-Risk GIST of the Stomach].
    Ishida T; Tamura S; Takeno A; Murakami K; Nose Y; Mori R; Oneda Y; Kuwahara R; Sakamoto T; Naito A; Katsura Y; Ohmura Y; Kagawa Y; Takeda Y; Kato T
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2392-2394. PubMed ID: 28133332
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Changes of diagnosis and treatment for gastrointestinal stromal tumors during a 18-year period in four medical centers of China].
    Qiu H; Zhang P; Feng X; Chen T; Sun X; Yu J; Chen Z; Li Y; Tao K; Li G; Zhou Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1265-1270. PubMed ID: 27928797
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Impressive long-term disease stabilization by nilotinib in two pretreated patients with KIT/pdgfra wild-type metastatic gastrointestinal stromal tumours.
    Pantaleo MA; Nannini M; Saponara M; Gnocchi C; Di Scioscio V; Lolli C; Catena F; Astolfi A; Di Battista M; Biasco G;
    Anticancer Drugs; 2012 Jun; 23(5):567-72. PubMed ID: 22430048
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Multimodality treatment with conventional transcatheter arterial chemoembolization and radiofrequency ablation for unresectable hepatocellular carcinoma.
    Ashoori N; Paprottka P; Trumm C; Bamberg F; Kolligs FT; Rentsch M; Reiser MF; Jakobs TF
    Digestion; 2012; 85(1):18-26. PubMed ID: 22156507
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Patterns of care, prognosis, and survival in patients with metastatic gastrointestinal stromal tumors (GIST) refractory to first-line imatinib and second-line sunitinib.
    Italiano A; Cioffi A; Coco P; Maki RG; Schöffski P; Rutkowski P; Le Cesne A; Duffaud F; Adenis A; Isambert N; Bompas E; Blay JY; Casali P; Keohan ML; Toulmonde M; Antonescu CR; Debiec-Rychter M; Coindre JM; Bui B
    Ann Surg Oncol; 2012 May; 19(5):1551-9. PubMed ID: 22065192
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Gastrointestinal stromal tumors.
    Antonescu C
    Curr Top Microbiol Immunol; 2012; 355():41-57. PubMed ID: 22015552
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Coexpression of PDGFR-alpha, PDGFR-beta and VEGF as a prognostic factor in patients with hepatocellular carcinoma.
    Chen L; Shi Y; Jiang CY; Wei LX; Lv YL; Wang YL; Dai GH
    Int J Biol Markers; 2011; 26(2):108-16. PubMed ID: 21574155
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. "Pediatric-type" gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior.
    Rege TA; Wagner AJ; Corless CL; Heinrich MC; Hornick JL
    Am J Surg Pathol; 2011 Apr; 35(4):495-504. PubMed ID: 21358303
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.